Alcohol Consumption and Risk of All-Cause and Cardiovascular Disease Mortality in Men by Howie, Erin K. et al.
University of South Carolina
Scholar Commons
Faculty Publications Epidemiology and Biostatistics
2011
Alcohol Consumption and Risk of All-Cause and
Cardiovascular Disease Mortality in Men
Erin K. Howie
University of South Carolina - Columbia
Xuemei Sui
University of South Carolina - Columbia
Duck-chul Lee
University of South Carolina - Columbia
Steven P. Hooker
University of South Carolina - Columbia
James R. Hébert
University of South Carolina - Columbia, jhebert@sc.edu
See next page for additional authors
Follow this and additional works at: https://scholarcommons.sc.edu/
sph_epidemiology_biostatistics_facpub
Part of the Public Health Commons
This Article is brought to you by the Epidemiology and Biostatistics at Scholar Commons. It has been accepted for inclusion in Faculty Publications by
an authorized administrator of Scholar Commons. For more information, please contact dillarda@mailbox.sc.edu.
Publication Info
Published in Journal of Aging Research, Volume 2011, Issue Article ID 805062, 2011, pages 1-10.
Howie, E.K., Sui, X., Lee, D., Hooker, S.P., Hébert, J.R., & Blair, S.N. (2011). Alcohol Consumption and Risk of All-Cause and
Cardiovascular Disease Mortality in Men. Journal of Aging Research, 2011(Article ID 805062), 1-10. doi:10.4061/2011/805062
Copyright © 2011 Erin K. Howie et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Author(s)
Erin K. Howie, Xuemei Sui, Duck-chul Lee, Steven P. Hooker, James R. Hébert, and Steven N. Blair
This article is available at Scholar Commons: https://scholarcommons.sc.edu/sph_epidemiology_biostatistics_facpub/11
SAGE-Hindawi Access to Research
Journal of Aging Research
Volume 2011, Article ID 805062, 10 pages
doi:10.4061/2011/805062
Research Article
Alcohol Consumption and Risk of All-Cause and
Cardiovascular Disease Mortality in Men
Erin K. Howie,1 Xuemei Sui,1 Duck-chul Lee,1 Steven P. Hooker,1, 2
James R. He´bert,3 and Steven N. Blair1, 3
1Department of Exercise Science, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA
2Prevention Research Center, University of South Carolina, Columbia, SC, USA
3Cancer Prevention and Control Program and Department of Epidemiology and Biostatistics, Arnold School of Public Health,
University of South Carolina, Columbia, SC, USA
Correspondence should be addressed to Erin K. Howie, howieek@email.sc.edu
Received 26 January 2011; Accepted 9 May 2011
Academic Editor: Leonard W. Poon
Copyright © 2011 Erin K. Howie et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This study examined the association between consumption of alcoholic beverages and all-cause and cardiovascular disease (CVD)
mortality in a cohort of men (n = 31,367). In the Cox proportional hazards model adjusted for age, year of examination, body
mass index (BMI), smoking, family history of CVD, and aerobic fitness, there were no significant diﬀerences in risk of all-cause
mortality across alcohol intake groups. Risk of CVD mortality was reduced 29% in quartile 1 (HR = 0.71, 95% confidence interval
(CI): 0.53, 0.95) and 25% in quartile 2 (HR = 0.75, 95% CI: 0.58, 0.98). The amount of alcohol consumed to achieve this risk
reduction was <6 drinks/week; less than the amount currently recommended. The addition of other potential confounders and
eﬀect modifiers including blood pressure, insulin sensitivity, lipid levels, and psychological variables did not aﬀect the magnitude
of association. Future research is needed to validate the current public health recommendations for alcohol consumption.
1. Introduction
Light-to-moderate alcohol consumption has been shown in
several prospective studies to reduce the risk of all-cause
mortality and several cardiac outcomes, including cardio-
vascular disease (CVD) mortality in men [1–10]. Several
hypotheses exist for the mechanism of this protective eﬀect
including increased exposure to antioxidants, improved
lipid profiles, reduced insulin resistance, decreased blood
coagulation, and modified inflammation pathways [11, 12].
Despite a large number of studies examining alcohol
consumption and mortality, questions remain about the
nature of this relationship. Three primary concerns include
the influence of confounding factors, appropriate public
health recommendations, and diﬀerential eﬀects between
types of alcohol [13, 14]. Selection bias is a particular
concern when comparing nondrinkers to drinkers. Non-
drinkersmay abstain from alcohol because of an initial health
condition and be more likely to have other conditions that
might confound the relationship including obesity, physical
inactivity, and overall health problems [14]. In addition,
moderate alcohol consumption has been associated with
positive psychosocial outcomes including sociability and
stress reduction, whichmay further confound the association
with mortality [15, 16]. Confounding is a limitation of
nonexperimental studies, yet it is unethical and impractical
to conduct long-term randomized controlled trials of alcohol
consumption. In an attempt to address this challenge,
investigators have used statistical methods to control for
possible confounders that may increase the risk of mortality
independent of alcohol consumption, but that may be
diﬀerentially distributed in those who drink alcohol versus
those who do not, such as smoking or physical inactivity.
Several problems have hampered the ability to construct
an appropriate public health message about alcohol con-
sumption. Methodological variation has led to inconsistent
estimates of protective amounts of alcohol and, thus, an
inability to quantify safe recommendations [17]. In addition,
any protective eﬀect must simultaneously be weighed against
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potential negative consequences. While several studies sup-
port light-to-moderate alcohol consumption as a protective
factor against CVD and all-cause mortality, excessive alcohol
intake has been associated with increased triglycerides, high
blood pressure, risk of some cancers, liver cirrhosis, heart
failure, and all-cause mortality [9, 12, 18]. Also, certain
cancers (e.g., breast) may be associated with increased risk
at low doses, but no dose response thereafter [19–21]. As
a result of these conflicting messages, the public may be
confused about the relationship between alcohol and health
outcomes.
The purpose of this study was to analyze the rela-
tionship between alcohol consumption and all-cause and
CVD mortality in a cohort of men while considering a
variety of potential confounding and modifying risk factors.
Additionally, diﬀerential eﬀects of types of alcohol on these
health outcomes were investigated.
2. Materials and Methods
2.1. Study Participants. Study participants were from the
Aerobics Center Longitudinal Study (ACLS) [22], a prospec-
tive epidemiological study of health outcomes in USA
adults. The sample for the current analyses was limited to
men, the majority of whom were white, middle to upper
income, received a baseline examination at the Cooper
Clinic in Dallas, Texas between 1974 and 2002 with at least
one year of followup, were aged ≥20 years at baseline,
were free of known CVD, cancer, or abnormal ECG, and
had complete information on alcohol intake and maximal
exercise treadmill test. Individuals participating in the ACLS
were either referred to the clinic by their employers or
physicians or through self-referral. The study was annually
reviewed and approved by the Cooper Institute Institutional
Review Board, and all participants gave written informed
consent for the baseline clinical examination and follow-up.
2.2. Primary Exposure Variable. Alcohol intake in drinks
per week among participants was self-reported at baseline.
Participants were asked, “How many 12-ounce drinks of
beer, 3-ounce drinks of wine (5-ounce drinks of wine during
more recent data collection cycles), and/or 1.5-ounce drinks
of hard liquor do you consume per week?” Self-report
alcohol intake has been previously validated against dietary
records in men (r = 0.86) [23, 24]. Participants were then
classified either as nondrinkers, or in quartiles of drinkers
based on baseline alcohol drinking reports.
2.3. Outcome Variables. All participants were followed from
the date of their baseline examination until their death or
December 31, 2003. Mortality surveillance was primarily
through the National Death Index. CVD mortality was
defined as the International Classification of Diseases, Ninth
Revision codes 390 to 449.9 before 1999 and Tenth Revision
codes I00 to I78 during 1999–2003.
2.4. Covariates. The baseline clinical assessment has been
previously described in detail [22, 25, 26]. At the baseline
visit patients completed a written survey and anthropomet-
ric, blood pressure, blood chemistry, and electrocardiogram
measures. BodyMass Index [BMI =weight (kg)/height (m)2]
was calculated from height and weight. Resting blood pres-
sure was assessed via ascultatory method [27]. Blood samples
were drawn after a 12-hour overnight fast, and analyzed for
fasting glucose and cholesterol using automated bioassays
according to the Centers for Disease Control and Prevention
Lipid Standardization Program. Hypertension, hypercholes-
terolemia, and diabetes were defined according to clinical
thresholds or self-reported as a previous diagnosis from
a physician. Hypertension was defined as resting systolic
or diastolic blood pressure ≥140/90mmHg, hypercholes-
terolemia was defined as total cholesterol ≥240mg/dL [28],
and diabetes was defined as fasting glucose≥126mg/dL [29].
The questionnaire included questions on smoking habits,
family history of CVD, and the presence of neuropsychiatric
conditions including anxiety, depression, suicidal thoughts,
or psychological counseling. Cardiorespiratory fitness (CRF)
was assessed using symptom-limited maximal treadmill
time during the modified Balke Protocol [22, 30]. Test
termination occurred by participant volition or physician
determined medical reasons. Test duration has been strongly
correlated with maximal oxygen uptake (r = 0.92) [31].
Cardiorespiratory fitness is a quantifiable, objective measure
with stronger associations to future health outcomes than
self-reported physical activity [32]. Treadmill times were
classified into fitness quintiles with the first quintile classified
as unfit and the remaining four quintiles as fit [33].
2.5. Statistical Analysis. Cox proportional hazards models
were used to calculate hazard ratios (HRs) and associated
95% confidence intervals. Alcohol consumption was the
primary exposure of interest. All-cause and CVD mortality
were fit as the outcomes (i.e., death or not, and time to event
or censoring) for survival analysis. Nondrinkers were used
as the referent group and those classified as drinkers were
categorized into quartiles of exposure. Linear and quadratic
trends were tested by fitting the continuous variable of
alcohol consumption in the basic model for both all-cause
and cardiovascular disease mortality. The basic model was
adjusted for age (in years), year of examination, BMI,
smoking (current smoker or not), family history of CVD
(yes or no), and treadmill time (minutes). Because blood
pressure [34], insulin sensitivity [35], and lipid levels [36]
have been shown tomediate the relationship between alcohol
and CVD mortality, they were added individually and then
simultaneously into the basic model. Finally, the full model
was adjusted for psychological variables [15, 16].
To examine eﬀect modification due to other health
risk factors, multivariate stratified analyses were conducted
for dichotomies based on age (<60 and ≥60 years), BMI
(<25 and ≥25 kg/m2), health status (healthy and unhealthy
defined as having at least one of the following diseases:
hypertension, diabetes, or hyperlipidemia), and fitness (least
fit 20% and most fit 80%) to test for eﬀect modification.
These models were adjusted for year of examination, smok-
ing, family history of CVD, and age, BMI, health status, and
fitness where appropriate.
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After analyzing the overall eﬀect of alcohol on mortality,
separate analyses were run for each type of alcohol (beer,
wine, and liquor), because of the potential diﬀerential eﬀects
from diﬀerent types of alcohol. As there were few men who
consumed a single beverage type, analysis was conducted
separately for quartiles of a single type of alcohol while
adjusting for the remaining type of alcohol consumption
[37, 38]. Alcohol consumption quartiles were created inde-
pendently for each alcohol type and hazard ratios adjusted
for age, year of examination, BMI, smoking, family history
of CVD, maximal treadmill time, and remaining types of
alcohol were calculated using nondrinkers as the reference
group.
3. Results and Discussion
A total of 31,637 men were included in the sample. The mean
age of men at baseline was 42.9 (standard deviation (SD):
9.2) years. Baseline characteristics are presented in Table 1.
Mean follow-up time was 16.0 (8.3) years for a total
of 504,735 person-years. There were 1,834 total deaths
and 588 CVD deaths. The rate of all-cause and CVD
mortality was calculated for the five drinking categories:
nondrinkers, quartile 1 (1–3 drinks/week), quartile 2 (4–6
drinks/week), quartile 3 (7–13 drinks/week), and quartile
4 (≥14 drinks/week). Alcohol consumption was linearly
associated with both all-cause and CVD mortality rate (P =
0.002 and P = 0.02).
3.1. Primary Analysis. In the basic model adjusted for age,
year of examination, BMI, smoking, family history of CVD,
and fitness, there were no significant diﬀerences in all-cause
mortality risks across alcohol intake groups (Table 2). There
was a lower risk of CVD mortality in quartile 1 (HR = 0.71,
95% confidence interval (CI): 0.53, 0.95) and quartile 2 (HR
= 0.75, 95% CI: 0.58, 0.98) in the basic model which is
less than 6 drinks per week (see Table 3). The addition of
potential intermediate variables of glucose, lipids, and blood
pressure, or the inclusion of all three, did not attenuate these
relationships. The additional adjustment for psychological
variables did not alter the observed associations and are not
included in the results presented.
3.2. Stratified Analysis. The lower risk of all-cause mortality
from light drinking (quartile 1) was attenuated when the
results were stratified by BMI, health status, and fitness (see
Table 4). However, men younger than 60 years in quartile 1
exhibited a significantly lower risk of all-cause mortality (HR
= 0.80, 95%CI: 0.66, 0.96); whereas, men 60 or older did not.
For CVD mortality, there were no significant findings
in men who were ≥60 years, had a BMI < 25 kg/m2, were
healthy, or unfit (see Table 5). Younger men had lower risk of
CVD mortality in quartile 1 (HR = 0.59, 95% CI: 0.43, 0.83)
and quartile 2 (HR = 0.70, 95% CI: 0.52, 0.93). Men with a
BMI >25 kg/m2 had lower CVD mortality risk in quartile 1
(HR = 0.67, 95% CI: 0.47, 0.94) and quartile 2 (HR = 0.71,
95% CI: 0.52, 0.97). Unhealthy men had a reduced risk in
quartile 3 (HR = 0.74, 95% CI: 0.54, 0.998). When stratified
by fitness, fit men exhibited a lower risk in quartile 2 (HR =
0.69, 95% CI: 0.49, 0.96).
3.3. Type of Alcohol. The results of the sensitivity analysis are
listed in Table 4. There were a total of 26,767 drinkers, of
which 23,728 reported drinking beer, 21,997 reported drink-
ing wine, and 20,416 reported drinking liquor. Therefore, for
this analysis, the types of alcohol drinking are not exclusive.
For all-cause mortality, there were no significant diﬀerences
in risk for any three of the alcohol types in comparison to
nondrinkers (see Table 6). For CVD mortality, there was a
lower risk with beer consumption in quartile 3 (HR = 0.72,
95% CI: 0.52, 0.995), wine consumption in quartile 2 (HR =
0.70, 95% CI: 0.53, 0.93) and liquor consumption in quartile
2 (HR = 0.71, 95% CI: 0.50, 0.93) and Q3 (HR = 0.69, 95%
CI: 0.55, 0.93) (see Table 7).
4. Discussion
4.1. All-Cause Mortality. In the current study, the rela-
tionship between risk of all-cause mortality with alcohol
consumption appeared to evince a flattened J-shaped curve
pattern. However, the risk reductions were significant only
at the lowest levels of alcohol consumption. Other studies
reporting on the association of alcohol consumption and
all-cause mortality in men have found protective eﬀects up
to three drinks per day [5]. In the Physicians Health Study,
Gaziano et al [3], found a reduction in all-cause mortality
with 5 to 6 drinks/week and reductions in CVD mortality
with all levels of alcohol consumption. Gaziano’s results are
consistent with ameta-analysis conducted by Di Castelnuovo
[39] which found a reduced risk for all-cause mortality up to
4 drinks per day.
4.2. Cardiovascular Disease Mortality. It has been hypoth-
esized that the lower CVD mortality risk associated with
limited alcohol intake is due to the cardioprotective eﬀects of
alcohol such as improved lipid profiles and decreased blood
coagulation [11, 12]. CVD contributes to 34.3% of all deaths
in the nation and is an important health outcome [40];
therefore, our results warrant consideration. In this sample,
32% of all deaths were attributed to CVD, similar to the
nationwide estimates. There was a 29% and 25% reduction
in risk for CVD mortality in the first and second quartiles of
alcohol consumption, respectively. This risk reduction was
found for 1–6 drinks per week. The lower risk of CVD death
may be balanced with an increase in other causes of death
potentially due to alcohol consumption, again complicating
public health recommendations.
The lower CVDmortality risk we observed was not atten-
uated when potential intermediate factors of blood pressure,
lipids, and glucose were added to the model, suggesting the
lower risks were not mediated by these factors. While Suh et
al. [7] and Djousse´ et al. [41] found that the reduced risk of
CVD mortality in women was mediated by lipids and insulin
sensitivity, other authors have found the relationship to be
independent of these risk factors. Arriola et al. [1] found
that blood pressure, cholesterol, and diabetes did not alter
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Table 1: Baseline demographics by alcohol consumption level, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
n 4870 6733 6150 6841 7043
Age (years) 43.63 (9.65) 42.15 (9.15) 42.34 (9.07) 42.95 (9.23) 43.62 (9.13)
Alcohol (drinks/week) 0 2.01 (0.76) 5.00 (0.87) 9.65 (1.93) 24.62 (13.64)
Body mass index (kg/m2) 26.65 (4.29) 26.63 (4.02) 26.36 (3.65) 26.28 (3.45) 26.42 (3.35)
Maximal treadmill time (min) 17.24 (5.15) 18.33 (4.89) 18.14 (4.90) 18.50 (4.84) 17.78 (4.83)
Current smokers (%) 10.62 14.18 19.50 22.03 29.09
Systolic blood pressure (mmHg) 121 (13) 121 (13) 121 (13) 121 (13) 122 (13)
Diastolic blood pressure (mmHg) 81 (10) 80.91 (9.47) 80.52 (9.35) 81.17 (9.41) 81.90 (9.53)
Hypertension (%)a 30.86 28.32 28.10 30.35 34.49
Fasting glucose (mg/dL) 99.14 (18.92) 99.20 (16.52) 98.80 (14.50) 99.74 (14.50) 101.13 (14.19)
Diabetes (%)b 4.58 4.92 4.70 4.37 4.91
Total cholesterol (mg/dL) 205.80 (38.56) 203.21 (39.88) 205.42 (38.29) 209.58 (39.16) 217 (40.42)
Triglycerides (mg/dL) 141.09 (104.59) 137.20 (106.77) 132.02 (94.37) 134.63 (101.78) 144.54 (105.24)
Hyperlipidemia (%)c 29.49 26.56 26.03 28.46 35.57
Unhealthy (%)d 49.63 46.81 45.69 48.68 55.93
Family history of CVD (%) 26.96 23.91 25.45 24.69 28.44
a
Defined as systolic or diastolic blood pressure ≥140/90mmHg or history of physician diagnosis.
bDefined as fasting glucose ≥126mg/dl or history of physician diagnosis.
cDefined as fasting total cholesterol ≥240mg/dl or triglyceride ≥200mg/dL.
dDefined as presence of one or more of following diseases: hypertension, diabetes, or hyperlipid.
Table 2: Hazard ratios of all-cause mortality by alcohol consumption level in men, Aerobics Center for Longitudinal Study (ACLS), 1974–
2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Person-years 86,872 91,529 98,303 103,625 124,360
No. 4870 6733 6150 6841 7043
No. of Deaths 343 237 350 349 555
Death ratea 43.8 37.2 43.3 41.6 51.2
Basic modelb 1.00 (referent) 0.86 (0.73–1.01) 0.95 (0.82–1.10) 0.97 (0.83–1.12) 1.09 (0.95–1.25)
Basic model plus
Blood pressure factorsc 1.00 (referent) 0.86 (0.73–1.02) 0.94 (0.81–1.09) 0.97 (0.83–1.12) 1.06 (0.92–1.21)
Fasting glucose factorsd 1.00 (referent) 0.84 (0.71–0.99) 0.95 (0.82–1.10) 0.96 (0.82–1.11) 1.07 (0.94–1.23)
Lipid factorse 1.00 (referent) 0.86 (0.73–1.01) 0.95 (0.82–1.11) 0.96 (0.83–1.12) 1.09 (0.95–1.25)
All intermediate factorscde 1.00 (referent) 0.84 (0.71–0.99) 0.94 (0.81–1.09) 0.96 (0.82–1.11) 1.05 (0.91–1.20)
a
Death rate per 10,000 person-years adjusted for age (in years).
bAdjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), and maximal treadmill
time (min).
cSystolic blood pressure and reported hypertension (yes or no).
dFasting glucose and reported diabetes (yes or no).
eTotal cholesterol and triglyceride.
their results and, through coronary angiography, Femia et al.
[42] found the risk for atherosclerosis and cardiac mortality
was independent of cholesterol, hypertension, and diabetes.
More research is needed to study the potential mechanisms
of alcohol intake on reduced CVD mortality risk.
4.3. Public Health Recommendations. Our results do not
support the currently recommended intake of 1-2 drinks
per day for men from the American Heart Association [43].
The lower alcohol consumption for risk reduction in our
study may result from complete adjustment for confounders
including fitness and thorough screening resulting in exclu-
sion of preclinical cases. There are large variations in results
from prospective studies examining alcohol consumption
and mortality making it diﬃcult to compare findings for
universal alcohol recommendations. In Di Castelnuovo et
al.’s [39] meta-analysis of all-cause mortality, they found
diﬀerences among genders, countries of the study, and
number of confounders. There has been large variation in
methods of reporting and categorizing alcohol consumption.
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Table 3: Hazard ratios of CVD mortality by alcohol consumption level in men, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Person-years 86,872 91,529 98,303 103,625 124,360
No. 4742 6663 6049 6735 6860
No. of Deaths 128 70 101 106 183
Death ratea 17.0 11.6 13.1 12.9 17.7
Basic modelb 1.00 (referent) 0.71 (0.53–0.95) 0.75 (0.58–0.98) 0.83 (0.64–1.08) 1.00 (0.80–1.26)
Basic model plus
Blood pressure factorsc 1.00 (referent) 0.70 (0.53–0.94) 0.73 (0.56–0.95) 0.84 (0.64–1.09) 0.94 (0.75–1.18)
Fasting glucose factorsd 1.00 (referent) 0.68 (0.51–0.91) 0.75 (0.58–0.98) 0.82 (0.63–1.07) 0.98 (0.78–1.24)
Lipid factorse 1.00 (referent) 0.71 (0.53–0.95) 0.73 (0.56–0.96) 0.80 (0.62–1.04) 0.95 (0.75–1.19)
All intermediate factorscde 1.00 (referent) 0.68 (0.51–0.91) 0.71 (0.55–0.93) 0.81 (0.62–1.05) 0.88 (0.69–1.11)
a
Death rate per 10,000 person-years adjusted for age (in years).
bAdjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), and maximal treadmill
time (min).
cSystolic blood pressure and reported hypertension (yes or no).
dFasting glucose and reported diabetes (yes or no).
eTotal cholesterol and triglyceride.
Table 4: Hazard ratios of all-cause mortality stratified by risk factorsa, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Age
Age <60 (n = 30, 263) 1.00 (referent) 0.80 (0.66–0.96) 0.92 (0.78–1.09) 1.02 (0.86–1.20) 1.08 (0.93–1.26)
Age ≥60 (n = 1, 374) 1.00 (referent) 0.86 (0.59–1.25) 0.85 (0.59–1.23) 0.75 (0.52–1.08) 1.04 (0.76–1.44)
BMI
BMI <25 (n = 12, 037) 1.00 (referent) 0.85 (0.65–1.11) 1.03 (0.80–1.32) 0.95 (0.74–1.22) 0.97 (0.77–1.23)
BMI ≥25 (n = 19, 600) 1.00 (referent) 0.86 (0.70–1.06) 0.90 (0.75–1.09) 0.96 (0.79–1.16) 1.12 (0.95–1.33)
Health statusb
Healthy (n = 15, 989) 1.00 (referent) 0.91 (0.69–1.20) 0.92 (0.71–1.19) 1.10 (0.86–1.42) 1.11 (0.87–1.41)
Unhealthy (n = 15, 648) 1.00 (referent) 0.82 (0.67–1.01) 0.97 (0.81–1.17) 0.88 (0.73–1.07) 1.05 (0.89–1.24)
Fitness level
Unfit (least fit 20%) (n = 5, 238) 1.00 (referent) 0.91 (0.67–1.22) 1.02 (0.79–1.32) 1.10 (0.83–1.44) 1.17 (0.92–1.48)
Fit (most fit 80%) (n = 26, 399) 1.00 (referent) 0.84 (0.69–1.03) 0.91 (0.76–1.10) 0.87 (0.73–1.05) 1.01 (0.85–1.19)
a
Adjusted for year of examination, smoking (current smoker or not), family history of CVD (yes or no), and each other factor in the table.
bDefined as presence or absence of one or more of following diseases: hypertension, diabetes, or hyperlipidemia.
Various authors have used diﬀerent definitions of drinks
ranging from 8 grams of alcohol per drink [10] to 22.8
grams [6]. Therefore, we did not attempt to impose grams of
alcohol conversion factors on self-reported drinks per week.
There is additional complexity when looking at the myriad of
cardiovascular outcomes. Previous studies have used various
outcomes including CVD mortality, cardiac mortality, CHD,
and myocardial infarction. For example, Beulens et al. [37]
found a reduction in risk of myocardial infarction, but not
in all-cause or CVD mortality. Due to such variation, it is
challenging to establish widespread recommendations for a
safe or protective amount of alcohol consumption as related
to CV health.
While a decrease in risk of all-cause mortality with
alcohol consumption was not found in this sample, there was
not a significantly increased risk with the highest amounts
of self-reported alcohol consumption. Klatsky [12] defined
heavy drinking as greater than 3 drinks per day, which is
consistent with the mean 24 drinks per week found in the
highest quartile of alcohol consumption in this study. While
our sample did not show a higher risk of either all-cause
or CVD mortality with the highest alcohol consumption,
there are other concerns in recommending drinking alcohol
including potential alcohol abuse. Rehm et al. [44] estimated
12.1% of disability-adjusted life years for men in the US were
attributed to alcohol-related causes with an estimated cost
of $235 billion dollars. Of problem drinkers, 82% report
drinking the moderate amount recommended to protect
against CVD [17]. Alcohol may be harmful in many ways,
even in small amounts (e.g., as a cocarcinogen with tobacco
smoke) [45].
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Table 5: Hazard ratios of CVD mortality stratified by risk factorsa, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Nondrinkers (0) Quartile 1 (1–3) Quartile 2 (4–6) Quartile 3 (7–13) Quartile 4 (≥14)
Age
Age < 60 (n = 30, 263) 1.00 (referent) 0.59 (0.43–0.83) 0.70 (0.52–0.93) 0.78 (0.58–1.04) 0.85 (0.66–1.11)
Age ≥ 60 (n = 1, 374) 1.00 (referent) 1.07 (0.57–2.00) 0.82 (0.43–1.57) 1.06 (0.59–1.91) 1.53 (0.92–2.54)
BMI
BMI < 25 (n = 12, 037) 1.00 (referent) 0.80 (0.47–1.37) 0.84 (0.51–1.39) 0.76 (0.46–1.25) 1.02 (0.66–1.59)
BMI ≥ 25 (n = 19, 600) 1.00 (referent) 0.67 (0.47–0.94) 0.71 (0.52–0.97) 0.82 (0.60–1.11) 0.91 (0.69–1.19)
Health statusb
Healthy (n = 15, 989) 1.00 (referent) 0.61 (0.32–1.16) 0.73 (0.42–1.28) 1.06 (0.63–1.79) 1.18 (0.72–1.92)
Unhealthy (n = 15, 648) 1.00 (referent) 0.73 (0.52–1.01) 0.76 (0.56–1.02) 0.74 (0.54–0.998) 0.90 (0.69–1.17)
Fitness level
Unfit (least fit 20%) (n = 5, 238) 1.00 (referent) 0.65 (0.39–1.08) 0.80 (0.52–1.22) 0.80 (0.50–1.27) 1.00 (0.68–1.44)
Fit (most fit 80%) (n = 26, 399) 1.00 (referent) 0.72 (0.51–1.04) 0.69 (0.49–0.96) 0.73 (0.53–1.00) 0.89 (0.67–1.19)
a
Adjusted for year of examination, smoking (current smoker or not), family history of CVD (yes or no), and each other factor in the table.
bDefined as presence or absence of one or more of following diseases: hypertension, diabetes, or hyperlipidemia.
Table 6: Hazard ratios of all-cause mortality stratified by types of alcohol beveragea, Aerobics Center for Longitudinal Study (ACLS), 1974–
2002.
Alcohol consumption (drinks/week)
Nondrinkers Quartile 1 Quartile 2 Quartile 3 Quartile 4
Beer (n = 23, 728)
No. 4870 3854 4876 5779 4349
No. of Cases 343 147 362 227 237
Hazard ratios 1.00 (referent) 0.87 (0.71, 1.06) 0.99 (0.84, 1.16) 0.90 (0.75, 1.07) 1.15 (0.96, 1.37)
Wine (n = 21, 997)
No. 4870 4091 4999 4175 3862
No. of Cases 343 177 370 183 196
Hazard ratios 1.00 (referent) 0.87 (0.72, 1.05) 0.92 (0.79, 1.08) 0.88 (0.73, 1.07) 0.95 (0.78, 1.14)
Liquor (n = 20, 416)
No. 4870 3111 5022 3562 3851
No. of Cases 343 126 383 247 423
Hazard ratios 1.00 (referent) 0.93 (0.75, 1.14) 0.96 (0.82, 1.12) 0.89 (0.75, 1.06) 1.13 (0.97, 1.32)
ACLS: Aerobics Center Longitudinal Study.
aAdjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), maximal treadmill time
(min), and remaining type of alcohol.
4.4. Stratified Analysis. The lower risk for all-cause mortality
was attenuated when stratified by BMI and health status,
but remained significant in younger men, consistent with
stratified results found by Sun et al. [8]. A meta-analysis
by Hvidtfeldt et al. [46] found a reduced risk of coronary
heart disease in all ages, and our null findings in the older
age group may be due to unequal sample size distributions
for each level, reducing power in the sparser strata. The
lower risk of CVD mortality in the current study remained
in younger, overweight, unhealthy, and fit men. Similarly,
the protective eﬀect of alcohol consumption has been shown
in populations with poor health status including men with
hypertension [37], cardiovascular disease [47], and vascular
disease including diabetes mellitus [2].
Interestingly, when the data were analyzed by fitness
levels, fit men had lower risks of CVD mortality with larger
alcohol consumption than did unfit men. This may be due
to a synergistic eﬀect as alcohol and fitness aﬀect similar
pathways such as lipid, glucose, and cholesterol metabolism.
It also may be due to fit nondrinkers having a higher risk due
to other latent variables (they may have been high risk and
as a result began to exercise and quit drinking). The diﬀerent
risks associated with stratified populations confirm that the
relationship between alcohol and mortality is complex and
may vary between population subgroups.
4.5. Type of Alcohol. The results of the sensitivity analysis
found no significant changes in risk of all-cause mortality
when alcohol consumption was stratified by type, consistent
with the overall analysis. Although for CVD mortality,
our findings suggest that there was a reduction in risk
of about 29% for moderate consumption of beer, wine,
and liquor. This reduction was most consistent with liquor
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Table 7: Hazard ratios of CVDmortality stratified by types of alcohol beveragea, Aerobics Center for Longitudinal Study (ACLS), 1974–2002.
Alcohol consumption (drinks/week)
Non Drinkers Quartile 1 Quartile 2 Quartile 3 Quartile 4
Beer (n = 23, 728)
No. 4870 3854 4876 5779 4349
No. of Cases 128 43 104 64 75
Hazard ratios 1.00 (referent) 0.71 (0.50, 1.02) 0.76 (0.57, 1.01) 0.72 (0.52, 0.995) 1.06 (0.78, 1.45)
Wine (n = 21, 997)
No. 4870 4091 4999 4175 3862
No. of Cases 128 55 104 55 64
Hazard ratios 1.00 (referent) 0.76 (0.55, 1.05) 0.70 (0.53, 0.93) 0.74 (0.53, 1.04) 0.89 (0.64, 1.23)
Liquor (n = 20, 416)
No. 4870 3111 5022 3562 3851
No. of Cases 128 36 112 74 144
Hazard ratios 1.00 (referent) 0.74 (0.51, 1.07) 0.71 (0.55, 0.93) 0.69 (0.50, 0.93) 0.98 (0.75, 1.27)
a
Adjusted for age (in years), year of examination, BMI (kg/m2), smoking (current smoker or not), family history of CVD (yes or no), maximal treadmill time
(min), and remaining type of alcohol.
consumption. Beulens et al. [37] also found that liquor
drinkers had the strongest association with decreased risk
of myocardial infarction. There have been inconsistencies,
however, when comparing the types of alcohol on mortality.
While several epidemiologic studies, including the current
study, have found no diﬀerences in risk between types of
alcohol consumed [1, 43, 48, 49], others have suggested
unique cardioprotection from wine [50]. Experimental stud-
ies have shown the ethanol in wine to have additional
protection compared to dealcoholized red wine [51]. The
diﬀerential eﬀects may depend on gender. Compared to de-
alcoholized beverages, women had increased adiponectin (an
anti-inflammatory factor also shown to be associated with
improved insulin sensitivity) after drinking red wine, while
men had increased levels after drinking liquor and beer [52].
4.6. Strengths and Limitations. Strengths of this study are
inclusion of several potential confounders including mea-
sures of fitness and psychological variables, lengthy follow-
up in a large cohort, exploration of relationships by health
risk factors, and stratification by alcohol types. The lim-
itations include that the sample was only men from the
Cooper Clinic in Dallas, Tex, USA, predominantly white,
and of middle to high incomes, limiting generalizations to
entire populations. However, the homogenous population
does eliminate potential confounding from gender [4] and
race [5, 28], both of which have been shown to influence
the relationship between alcohol and mortality. Additionally,
this regional population is similar in physiologic variables
to other North American populations [53]. The mean age
of 43 at baseline with an average follow-up time of 16
years makes these findings particularly relevant for an aging
American population. When stratified by age, we did not
find a significant association in the older men, but this may
have been due to a small sample of men above 60. Future
studies are needed to confirm the lower levels of alcohol
consumption found to be protective in this study population.
Clearly, more work will be required in populations that diﬀer
in racial and ethnic composition to that of the ACLS.
While self-reported alcohol consumption has been val-
idated [23], under or overreporting could have influenced
the trends in risk reduction in either direction. The format
of response did not allow assessment of varied drinking
patterns including daily frequency of alcohol consumption.
Studies have suggested that alcohol should be consumed in
small amounts over multiple occasions for health benefits
rather than binge drinking [54]. In the sensitivity analyses,
it was not possible to isolate single types of drinkers due to
low prevalence of single alcohol-type drinkers.
Despite adjustment for many confounders, confounding
may still exist in this and other prospective studies. One
potential confounder not adjusted for was diet, particularly
fat intake, which plays an established role in cardiovascular
outcomes. We did, however, measure and control for blood
cholesterol levels which is associated with dietary fat intake
[55].
Consistent with previous studies, we used nondrinkers
as the referent group [5, 43, 56]. Some researchers have
argued against using nondrinkers as the referent group due
to confounding predisposing conditions or other latent vari-
ables contributing to diﬀerential mortality risk independent
of alcohol consumption [10]. Mukamal et al. [14] found
that nondrinkers are more likely to be in poor health,
obese, of low income, or physically inactive; however, they
did not exclude or report whether the participants had
preexisting vascular disease. In contrast, when adjusted for
preexisting disease (excluded or controlled for in ourmodel),
Wannamethee and Shaper [10] found ex-drinkers and life-
long nondrinkers had equal CVDmortality and almost equal
all-cause mortality. When Hart and Smith [56] examined
the health status of nondrinkers to drinkers, they did not
diﬀer substantially. Friesema et al. [57] found that the inverse
relationship between alcohol consumption and mortality
could not be explained by health status alone. Potential
confounding would have a less likely eﬀect on CVDmortality
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as Klatsky and Udaltsova [5] found that the excess mortality
seen in nondrinkers is not related to CVD.
This study attempted to account for any “sick quitters”
(former drinkers who stopped due to an adverse health
condition) through in-depth baseline assessments to rule
out underlying disease and adjustment for confounders. In
asymptomatic men, especially with risk factors for CVD,
exercise testing has been shown to be a valid predictor of
future CVDmortality [58] beyond reported risk factors [59].
In addition, we examined if the risk association varied by
levels of these risk factors (health status, age, BMI, and fitness
status).
5. Conclusion
We found a trend towards reduction in risk of all-cause
mortality with self-reported alcohol consumption and a
reduction in risk of CVDmortality with one to six drinks per
week, when adjusting for several potential confounders in a
large sample of men. The amount of alcohol consumption
associated with a reduced risk of CVDmortality was less than
the current public health recommendations of 1-2 drinks
per day. A lack of consensus on the amount and type of
alcohol for protective eﬀects and other potential harmful
consequences of alcohol abuse calls for caution whenmaking
public health recommendations for alcohol consumption.
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